Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2021-04-07 2021-04-07
Drug Identification Number 02240518 02240518
Brand name MAXALT RPD MAXALT RPD
Common or Proper name rizatriptan benzoate wafers rizatriptan benzoate wafers
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 5MG 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 12 12
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-06-04 2021-06-04
Actual start date
Estimated end date 2021-07-16 2021-07-16
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Company comments
Health Canada comments